A head-to-head trial comparing weight-loss drugs Mounjaro and Wegovy reveals Mounjaro's superior effectiveness. Mounjaro achieved a 20% weight reduction over 72 weeks, surpassing Wegovy's 14%. While both drugs curb appetite, Mounjaro targets two appetite switches versus Wegovy's one. Mounjaro also showed better improvements in blood pressure, blood sugar, and cholesterol. Although both had similar side effects, and Wegovy has additional health benefits, Mounjaro's greater weight loss may make it preferable for those needing more significant weight reduction.

Prepared by Olivia Bennett and reviewed by editorial team.